VO
Vivo Opportunity Fund Holdings, L.P. disclosed a 10% stake in KTTA
Vivo Opportunity Fund Holdings, L.P. reported owning 10% of Pasithea Therapeutics Corp. (KTTA) (9,202,561 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G